Hydrochloric Acid

Hydrochloric Acid

SCHEMBL491727

CCCCCCCCCCCC[N+](O)(O)CCC.[Cl-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 2/20 0.52
DNM1 Q05193 8/20 0.52
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HTT P42858 1/20 0.48
SLC22A2 O15244 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL721018 1.00 SLC22A1 (0.52) SLC22A1DNM1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL9575880 1.00 SLC22A1 (0.52) SLC22A1DNM1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL4893513 1.00 SLC22A1 (0.52) SLC22A1DNM1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL4895225 1.00 SLC22A1 (0.52) SLC22A1DNM1ALDH1A1TP53CYP3A4
SCHEMBL11466080 0.97 SLC22A1 (0.55) SLC22A1DNM1ALDH1A1TP53CYP3A4
SCHEMBL15973366 0.97 SLC22A1 (0.55) SLC22A1DNM1ALDH1A1TP53CYP3A4
SCHEMBL7702551 0.97 SLC22A1 (0.55) SLC22A1DNM1ALDH1A1TP53CYP3A4
SCHEMBL2839296 0.97 SLC22A1 (0.55) SLC22A1DNM1ALDH1A1TP53CYP3A4
Bromide SCHEMBL2858689 0.95 ALDH1A1 (0.57) SLC22A1DNM1ALDH1A1TP53CYP3A4
Bromide SCHEMBL11127927 0.95 ALDH1A1 (0.57) SLC22A1DNM1ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12578665-B2 Toner producing method RICOH COMPANY, LTD. (JP) 2026-03-17 US disclosed
US-20230305413-A1 TONER, DEVELOPER, TONER-STORING UNIT, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, AND TONER PRODUCING METHOD RICOH COMPANY, LTD. (JP) 2023-09-28 US disclosed
US-20210389686-A1 TONER, TONER ACCOMMODATING UNIT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2021-12-16 US disclosed
US-10303075-B2 Toner CANON KABUSHIKI KAISHA (JP) 2019-05-28 US disclosed
US-20180246430-A1 TONER CANON KABUSHIKI KAISHA (JP) 2018-08-30 US disclosed
US-9885969-B2 Carrier for two-component developer, two-component developer, and method of preparing carrier for two-component developer FUJI XEROX CO., LTD. (JP) 2018-02-06 US disclosed
US-20170277054-A1 CARRIER FOR TWO-COMPONENT DEVELOPER, TWO-COMPONENT DEVELOPER, AND METHOD OF PREPARING CARRIER FOR TWO-COMPONENT DEVELOPER FUJI XEROX CO., LTD. (JP) 2017-09-28 US disclosed
US-9733593-B2 Electrostatic charge image developing carrier, electrostatic charge image developer, developer cartridge, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2017-08-15 US disclosed
US-20160026120-A1 ELECTROSTATIC CHARGE IMAGE DEVELOPING CARRIER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, DEVELOPER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2016-01-28 US disclosed
US-9182693-B2 Toner to develop electrostatic charge image, device to supply toner, and apparatus and method to form an image by using toner SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-11-10 US disclosed
US-20040253530-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2004-12-16 US disclosed
US-20040152004-A1 Toner having specific relation between absorption soectra, and developer, image forming method and image forming apparatus using same FUJI XEROX CO., LTD. (JP) 2004-08-05 US disclosed
US-6733944-B2 FORMING LATENT IMAGES; DEVELOPMENT WITH TONER; TRANSFERRING TO RECEIVERS; HEAT FIXING; PRESSURIZATION FUJI XEROX CO., LTD. (JP) 2004-05-11 US disclosed
US-20030116061-A1 Inorganic composition, film, and method of producing film FUJI PHOTO FILM CO., LTD. 2003-06-26 US disclosed
US-6582867-B2 A crystalline binder resin and a fatty acid ester or a resin having a contact angle with water that is smaller than that of the crystalline resin; electrography; reproducibility in particle size/distribution; low-temperature fixing; stability FUJI XEROX CO., LTD. (JP) 2003-06-24 US disclosed
US-20030113650-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2003-06-19 US disclosed
US-20030039913-A1 Image forming process FUJI XEROX CO., LTD (JP) 2003-02-27 US disclosed
EP-1281689-A2 Inorganic composition, film made therefrom, and method for producing such film FUJI PHOTO FILM CO., LTD. (JP) 2003-02-05 EP disclosed
US-20020055050-A1 Toner for developing electrostatic latent image, process for producing the same, and process for forming image FUJI XEROX CO., LTD. (JP) 2002-05-09 US disclosed
US-6294302-B1 EXCELLENT IN SMOOTHNESS, EXHIBITS SMALL UNEVENNESS OF GLOSS, AND HAS HIGH IMAGE QUALITY AND HIGH RELIABILITY. FUJI XEROX CO., LTD. (JP) 2001-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12578665-B2 Toner producing method HEATR1, KDELR1, H1-0 SLC22A1 2833/4885DNM1 1071/4885ALDH1A1 4125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.